Filing Flows › Eton Pharmaceuticals (ETON) › Operating margin
Eton Pharmaceuticals (ETON) operating margin by quarter
Eton Pharmaceuticals' operating margin was 39.7% in Q3 2026 (third quarter 2026), +5.7 pts from Q2 2026. Over the last 4 quarters it ranged from 9.9% (Q1 2026) to 39.7% (Q3 2026).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 39.7% | +5.7 pts | — |
| Q2 2026 | 34.0% | +24.1 pts | — |
| Q1 2026 | 9.9% | -1.6 pts | — |
| Q4 2025 | 11.6% | — | — |
Q3 2026 at a glance
Eton Pharmaceuticals, Q3 2026: revenue $57.9M (+158% year over year), operating margin 39.7%, net earnings $35.2M, operating cash flow $35.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is Eton Pharmaceuticals' operating margin?
Eton Pharmaceuticals' operating margin was 39.7% in Q3 2026 (third quarter 2026), +5.7 pts from Q2 2026.
How has Eton Pharmaceuticals' operating margin changed?
Over the last 4 quarters it ranged from 9.9% (Q1 2026) to 39.7% (Q3 2026).